Metoprolol: Clinical Trials

249 trials of Metoprolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

149 completed, 36 unknown, 29 terminated, 12 withdrawn. 94 Phase 4, 46 Phase 1, 41 Phase 3, 33 Not applicable, 33 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 494Completed 55, Unknown 16, Terminated 9, Recruiting 4, Not yet recruiting 3, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 2
Phase 146Completed 40, Unknown 3, Terminated 2, Withdrawn 1
Phase 341Completed 21, Terminated 10, Unknown 4, Recruiting 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1
Not applicable33Completed 15, Terminated 4, Unknown 4, Withdrawn 4, Recruiting 3, Not yet recruiting 2, Enrolling by invitation 1
Phase 233Completed 15, Unknown 7, Terminated 6, Withdrawn 4, Enrolling by invitation 1
Early Phase 13Completed 2, Terminated 1

Follow Metoprolol: new trials by email Literature Review of Metoprolol trials Research Report on Metoprolol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
Verapamil Hydrochloride, Metoprolol tartrate - Atrial Fibrillation (AF), Atrial Fibrillation With Rapid Ventricular Response
Phase 4Not yet recruitingMuhammad Ali Javed1202027-01-012026-08-03
Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx) - Heart Failure With Reduced Ejection Fraction
Phase 4RecruitingUniversity of Michigan1002026-12-012026-10-15
Predicting Response and Exposure Changes in Cirrhosis for Effectiveness
Five-Drug CYP Probe Cocktail - Liver Cirrhosis
Not applicableNot yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)452026-11-012026-08-11
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
BHB-1893, Metoprolol - Cardiomyopathy, Hypertrophic Obstructive
Phase 3RecruitingBraveheart Bio, Inc.2102026-09-022026-11-10
Dose-Response Interaction of Metoprolol and Sufentanil for Attenuating Hemodynamic Responses in Tracheal Intubation
Metoprolol (MET), Sufentanil, Normal Saline (0.9% NaCl) - General Anesthesia; Tracheal Intubation
Phase 4Not yet recruitingFujian Provincial Hospital9002026-06-222026-05-20
SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation
Verapamil 240 mg slow-release tablet, metoprolol 100 mg slow-release tablet - Atrial Fibrillation (AF)
Phase 4Not yet recruitingMartini Hospital Groningen4362026-06-012026-03-27
Pharmacological Intervention to Prevent NOAF After TAVR
Metoprolol succinate, Amiodarone - Atrial Fibrillation
Not applicableNot yet recruitingShanghai East Hospital1982026-04-072026-04-15
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
Not applicableEnrolling by invitationEnhanced Emirates Limited602026-03-122026-05-06
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
mavacamten, Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol, diltiazem - Hypertrophic Cardiomyopathy (HCM)
Phase 4Enrolling by invitationSecond Affiliated Hospital, Zhejiang University, School of Medicine1322026-03-012026-09-15
Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
Placebo (matching), Beta-blockers - Heart Failure, HFpEF
Phase 4Enrolling by invitationWeill Medical College of Cornell University2402026-02-022026-10-16
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)
Phase 2 / Phase 3Enrolling by invitationGødstrup Hospital3502025-12-152025-12-17
Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries
Atenolol Succinate Oral Tablet, Metoprolol Succinate Oral Tablet - Hypotension Drug-Induced
Phase 4RecruitingDamanhour Teaching Hospital602025-12-012026-09-21
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
Metoprolol Succinate, Carvedilol - Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death
Phase 4RecruitingUniversity of Rochester20002025-08-172025-09-18
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Saline (NaCl), Metoprolol Tartrate - Coronary Arterial Disease (CAD), Angina (Stable)
Phase 4RecruitingVZW Cardiovascular Research Center Aalst462025-07-032025-07-14
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Metoprolol (MET), Plcacebo - ST Segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Post Myocardial Infarction
Not applicableRecruitingTel-Aviv Sourasky Medical Center2002025-05-212025-05-28
To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants
Retatrutide, Metoprolol - Healthy
Phase 1CompletedEli Lilly and Company302025-02-032025-06-05
An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates
Amlitelimab, Midazolam, Caffeine - Dermatitis Atopic
Phase 1CompletedSanofi232024-11-202026-04-23
Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)
Metoprolol, Placebo - Non-Traumatic Subarachnoid Hemorrhage
Phase 4Active not recruitingMadeleine Puissant202024-09-232026-10-19
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Metoprolol Injection, saline 0.9% - Acute Respiratory Distress Syndrome (ARDS)
Phase 3TerminatedConsorcio Centro de Investigación Biomédica en Red (CIBER)142024-07-102026-06-02
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Metoprolol Succinate, Carvedilol - End-Stage Kidney Disease, End-Stage Renal Disease
Phase 3RecruitingVA Office of Research and Development25402024-05-222026-10-13

Showing 20 of 249. Sign in to see all of them.

Conditions studied

Hypertension (63)  ·  Atrial Fibrillation (22)  ·  Heart Failure (17)  ·  Cardiovascular Diseases (11)  ·  Coronary Artery Disease (10)  ·  Diabetes Mellitus (9)  ·  Diabetes Mellitus, Type 2 (9)  ·  Heart Diseases (9)  ·  Arrhythmias, Cardiac (5)  ·  Cardiomyopathy, Hypertrophic (5)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Acute Coronary Syndrome (4)  ·  Burns (4)  ·  Cardiomyopathies (4)  ·  Dermatitis, Atopic (4)

Sponsors

AstraZeneca (8)  ·  Saniona (7)  ·  GlaxoSmithKline (5)  ·  Boehringer Ingelheim (4)  ·  Forest Laboratories (4)  ·  Mayo Clinic (4)  ·  Mylan Pharmaceuticals Inc (4)  ·  The University of Texas Medical Branch, Galveston (4)  ·  Weill Medical College of Cornell University (4)  ·  China National Center for Cardiovascular Diseases (3)  ·  Creighton University (3)  ·  Eli Lilly and Company (3)  ·  IPCA Laboratories Ltd. (3)  ·  Kuopio University Hospital (3)  ·  The George Institute (3)

Countries

United States (114)  ·  China (25)  ·  Germany (14)  ·  Canada (10)  ·  Denmark (9)  ·  Sweden (7)  ·  India (6)  ·  Netherlands (6)  ·  United Kingdom (6)  ·  Australia (5)  ·  Hungary (5)  ·  Italy (5)  ·  Norway (5)  ·  Spain (5)  ·  Finland (4)

Top investigators

David N Herndon, MD (4)  ·  Shoujun Li, MD (3)  ·  Ahmed M Shaat, MD (2)  ·  Craig Anderson, PhD (2)  ·  Dr. Manish Singhal, M.B.B.S (2)  ·  Dr. P. Vijaya Lakshmi, Clinical Investigator (2)  ·  Italo Biaggioni, MD (2)  ·  James D Carlson, Pharm. D. (2)  ·  Jie Wang, MD (2)  ·  Julie A Johnson, PharmD (2)  ·  Kim Krogsgaard, MD, DMSc (2)

Results publications

PMID 32640944, PMID 17236889, PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 23303884, PMID 24694530, PMID 25503550, PMID 25589782, PMID 25657175, PMID 25712944, PMID 25823544, PMID 26746184, PMID 27165954, PMID 27178897, PMID 27480425, PMID 27847338, PMID 27919055, PMID 28115488, PMID 29523524, PMID 29925376, PMID 30753254, PMID 30890109, PMID 31085948, PMID 33598552, PMID 36526898, PMID 38018833, PMID 38353215, PMID 38747311, PMID 40541207, PMID 41855454, PMID 42848972, PMID 10342782, PMID 10851208, PMID 11386927, PMID 11581560, PMID 11799102, PMID 11927799, PMID 12119802, PMID 12435255, PMID 12923400, PMID 15738343, PMID 16235327, PMID 1627164, PMID 16271642, PMID 16271643, PMID 16391172, PMID 16476851, PMID 16533484

NIH funding

2005 (2), 2015 (2), 2018 (2), 2025 (2), 1UL1TR002373-01 (1), 2014 (1), 2016 (1), 2023 (1), K23AG030057 (1), K23GM110516 (1), K23HL146887 (1), K76AG064428 (1), N01HC95178 (1), N01HC95179 (1), N01HC95180 (1)